Table 1 Demographic and clinical characteristics of participants (N = 248)
From: Tacrolimus trough levels in kidney transplant recipients
Characteristics | Classification | n (%), mean ± SD (min–max) |
|---|---|---|
Sex | Male | 149 (60.1) |
Female | 99 (39.9) | |
Age (years) | 53.68 ± 12.18 (25–76) | |
Type of donor | Deceased | 120 (48.4) |
Living | 128 (51.6) | |
Retransplant | Yes | 22 (8.9) |
Pretransplant kidney disease | IgA nephropathy | 42 (16.9) |
DM ESRD | 33 (13.3) | |
Glomerular nephropathy | 27 (10.9) | |
ADPKD | 21 (8.5) | |
Unknown | 74 (29.8) | |
HT | 17 (6.9) | |
Others | 34 (13.7) | |
BMI | < 18.5 | 26 (10.5) |
18.5–24.9 | 162 (65.3) | |
> 24.5 | 60 (24.2) | |
Posttransplant period (months) | 90.71 ± 9.82 (75.0–110.0) | |
Tacrolimus dose change | Yes | 93 (37.5) |
Rejection | Yes | 11 (4.4) |
Tacrolimus trough level | Mean | 6.00 ± 1.07 (2.93–9.38) |
SD | 1.51 ± 1.09 (0.35–9.34) | |
CV | 0.25 ± 0.14 (0.70–1.20) |